Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강수성 | * |
dc.date.accessioned | 2022-10-27T16:31:11Z | - |
dc.date.available | 2022-10-27T16:31:11Z | - |
dc.date.issued | 2022 | * |
dc.identifier.issn | 1948-5875 | * |
dc.identifier.other | OAK-32358 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/262658 | - |
dc.description.abstract | Glutaminyl cyclases (QC, isoQC) convert N-terminal glutamine or glutamate into pyroglutamate (pGlu) on substrates. IsoQC has recently been demonstrated to promote pGlu formation on the N-terminus of CD47, the SIRP alpha binding site, contributing to the & ldquo;don & rsquo;t eat me & rdquo; cancer immune signaling of CD47-SIRP alpha. We developed new QC inhibitors by applying a structure-based optimization approach starting from fragments identified through library screening. Screening of metal binding fragments identified 5-(1H-benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine (9) as a potent fragment, and further modification provided 5-(1-(3-methoxy-4-(3-(piperidin-1-yl)propoxy)benzyl)-1H-benzo[d]imidazol-5-yl)-1,3,4-thiadiazol-2-amine (22b) as a potent QC inhibitor. Treatment with 22b in A549 and H1975 lung cancer cells decreased the CD47/alpha hCD47-CC2C6 interaction, indicative of the CD47/SIRP alpha interaction, and enhanced the increased phagocytic activity of both THP-1 and U937 macrophages. <comment>Superscript/Subscript Available</comment | * |
dc.language | English | * |
dc.publisher | AMER CHEMICAL SOC | * |
dc.subject | QC | * |
dc.subject | isoQC | * |
dc.subject | inhibitor | * |
dc.subject | metalloprotein | * |
dc.subject | fragment | * |
dc.subject | CD47 | * |
dc.subject | SIRP? | * |
dc.subject | cancer immunotherapy | * |
dc.subject | fibrosis | * |
dc.subject | Alzheimer?s disease | * |
dc.title | 2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRP alpha Checkpoint | * |
dc.type | Article | * |
dc.relation.issue | 9 | * |
dc.relation.volume | 13 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 1459 | * |
dc.relation.lastpage | 1467 | * |
dc.relation.journaltitle | ACS MEDICINAL CHEMISTRY LETTERS | * |
dc.identifier.doi | 10.1021/acsmedchemlett.2c00256 | * |
dc.identifier.wosid | WOS:000859701300001 | * |
dc.identifier.scopusid | 2-s2.0-85136725260 | * |
dc.author.google | Park, Eunsun | * |
dc.author.google | Song, Kyung-Hee | * |
dc.author.google | Kim, Darong | * |
dc.author.google | Lee, Minyoung | * |
dc.author.google | Nguyen Van Manh | * |
dc.author.google | Kim, Hee | * |
dc.author.google | Hong, Ki Bum | * |
dc.author.google | Lee, Jeewoo | * |
dc.author.google | Song, Jie-Young | * |
dc.author.google | Kang, Soosung | * |
dc.contributor.scopusid | 강수성(56177300500) | * |
dc.date.modifydate | 20240301081003 | * |